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Health and Social Care, Bologna, ItalyAbstractWe performed a quasi-experimental study of a multifaceted infection control programme for reducing carbapenem-resistant
Enterobacteriaceae (CRE) transmission and bloodstream infections (BSIs) in a 1420-bed university-afﬁliated teaching hospital during
2010–2014, with 30 months of follow-up. The programme consisted of the following: (a) rectal swab cultures were performed in all
patients admitted to high-risk units (intensive-care units, transplantation, and haematology) to screen for CRE carriage, or for any room-
mates of CRE-positive patients in other units; (b) cohorting of carriers, managed with strict contact precautions; (c) intensiﬁcation of
education, cleaning and hand-washing programmes; and (d) promotion of an antibiotic stewardship programme carbapenem-sparing
regimen. The 30-month incidence rates of CRE-positive rectal cultures and BSIs were analysed with Poisson regression. Following the
intervention, the incidence rate of CRE BSI (risk reduction 0.96, 95% CI 0.92–0.99, p 0.03) and CRE colonization (risk reduction 0.96,
95% CI 0.95–0.97, p <0.0001) signiﬁcantly decreased over a period of 30 months. After accounting for changes in monthly census and
percentage of externally acquired cases (positive at 72 h), the average institutional monthly rate of compliance with CRE screening
procedures was the only independent variable associated with a declining monthly incidence of CRE colonization (p 0.002). The monthly
incidence of CRE carriage was predictive of BSI (p 0.01). Targeted screening and cohorting of CRE carriers and infections, combined with
cleaning, education, and antimicrobial stewardship measures, signiﬁcantly decreased the institutional incidence of CRE BSI and
colonization, despite endemically high CRE carriage rates in the region.
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rights reserved.
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p://dx.doi.org/10.1016/j.cmi.2014.10.020IntroductionThe emergence of carbapenemase-resistant Enterobacteriaceae
(CRE) represents a major public health threat [1].
Institutional prevention programmes were developed on the
basis of the early identiﬁcation of CRE-colonized patients
through rectal surveillance cultures [2,3] (CDC. Guidance for
control of carbapenemase-resistant enterobacteriaceae. 2013.
www.cdc.gov/hai/organisms/cre/cre-toolkit). Patients colonizedious Diseases. Published by Elsevier Ltd. All rights reserved
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mize CRE transmission in the hospital. This approach has been
previously shown to reduce the frequency of CRE infections in
acute-care and long-term-care settings [2–5], and is recom-
mended as a primary strategy, with antimicrobial stewardship,
for reducing the overall mortality associated with CRE in-
fections (CDC. Guidance for control of carbapenemase-
resistant enterobacteriaceae. 2013. www.cdc.gov/hai/
organisms/cre/cre-toolkit). Nevertheless, relatively few studies
have documented the effectiveness of these prevention stra-
tegies when applied to a large, teaching, tertiary-care medical
centre located in a region with high endemic rates of CRE
colonization.
Herein, we describe the outcomes of a comprehensive,
multifaceted infection control intervention for CRE in our
institution based on targeted active screening integrated by
automatic reporting of any CRE isolation (cases and colonized),
contact isolation of CRE carriers, expanded hand-washing and
environmental cleaning, education and training of medical staff,
and a stewardship programme targeting carbapenem use.Materials and methodsSetting
S. Orsola-Malpighi Hospital is a 1450-bed tertiary-care univer-
sity hospital in Bologna in the region of Emilia-Romagna
(northern Italy). The hospital comprises eight (8–16-bed)
intensive-care units, 12 surgical units, three transplant units,
two dialysis centres, medicine wards, and numerous day-
hospital services and rehabilitation units. The hospital has an
average of 72 000 admissions per year, with a yearly occupancy
of ~82%. Most patients are cared for in four-bed rooms in
medical wards, or in two-bed rooms in surgical and transplant
units, with the same nursing staff caring for the patients housed
in the same room. Intensive-care units are organized in open
space, with a nurse/patient ratio of 2. An infectious disease
consultant team has been active since 2010, with an overall
number of consultations of ~4000 per year.
Study design and intervention
We performed a quasi-experimental study comparing a
16-month pre-intervention period, from June 2010 to July
2011, with an interventional period from August 2011 to
January 2014, to assess the impact of an infection control
programme on the incidence of CRE bloodstream infections
(BSIs). Speciﬁcally, we analysed the ratio of CRE BSIs to CRE
stool carriers during the intervention period. We also ana-
lysed the incidence of CRE isolation from any other site be-
sides blood and stool cultures. Finally, compliance with theClinical Microbiology and Infection © 2014 European Society of Clinical Microbiologyprogramme was assessed by evaluating adherence to
screening for CRE carriage.
The CRE infection control intervention consisted of a
number of measures, shown in Appendix S1.
Deﬁnitions
Rectal carrier patients were deﬁned as patients with CRE
isolation from the rectal swab in the absence of symptoms and
signs of invasive infection. CRE BSI was deﬁned according to
CDC criteria [6].
Microbiology
CRE carriers were identiﬁed by rectal swabs, which were
inoculated on a chromogenic agar plate (Oxoid Brilliance CRE;
Thermo Fisher Scientiﬁc, Loughborough, UK) containing a
carbapenem antibiotic as the selective agent. Clinical specimens
were processed in accordance with the CLSI guidelines [7], and
isolates were identiﬁed with the Vitek 2 semi-automated system
(Biomérieux, Marcy l’Etoile, France). Carbapenem MICs for
bloodstream Klebsiella pneumoniae isolates were conﬁrmed by
Etest (Biomérieux). Carbapenemase production was conﬁrmed
with a disk diffusion synergy test (Rosco Diagnostica, Taastrup,
Denmark). Enterobacteriaceae resistant to one or more carba-
penems were deﬁned as CRE. All MICs were interpreted ac-
cording to EUCAST guidelines [8].
Statistical analysis
The primary endpoint for analysis was the institutional monthly
incidence of CRE BSI and positive rectal swab cultures. We
deﬁned all rates of BSI and rectal carriage as a monthly inci-
dence, even if it was not possible to conﬁrm each infection or
colonization episode as de novo relative to the previous month.
The monthly BSI incidence was calculated by using as numer-
ator the ﬁrst positive blood culture per patient per month, and
as the denominator the monthly hospital patient census. In the
case of BSI incidence per unit, the denominator was the
monthly patient census per unit. The incidence of rectal car-
riers was calculated by using as numerator the ﬁrst positive
stool culture per patient and patient census data as described
above. We also calculated the fraction of positive rectal swab
cultures submitted per month. Patients with a positive rectal
culture within 72 h of admission were considered to be ‘im-
ported cases’ from outside the institution.
Finally, we examined the incidence of non-bloodstream CRE
isolates by using only the ﬁrst isolate per site each month per
patient.
Trends in CRE incidence were analysed with segmented and
mixed-effects Poisson regression. Speciﬁcally, we used
segmented Poisson regression to estimate the rates of reduc-
tion in CRE BSI pre-intervention and post-intervention. Trendsand Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 242–247
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during the intervention period by use of a Poisson regression
model with inclusion of random effects for the monthly hospital
census, the monthly incidence of CRE-positive rectal cultures
per month, the fraction of ‘imported cases’, and average insti-
tutional rates of compliance with screening procedures. The
monthly rectal CRE incidence was analysed with the same
approach, with inclusion of the fraction of imported cases, the
monthly hospital census, and average institutional compliance.
The autoregressive structure in monthly BSI incidence or CRE
rectal carriage was screened by the use of correlogram plots,
and corrected by lagging the dependent variable. Model ﬁt was
assessed with the deviance (likelihood ratio) statistic, and visual
examination predicted residuals in a correlogram to ensure
adequate model ﬁt and exclude the possibility of excessive runs
of positive or negative residuals. For all calculations, a two-sided
p-value of <0.05 was considered to be signiﬁcant. All statistical
analyses were performed with Stata 13 (StataCorp, College
Station, TX, USA).Results0
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FIG. 1. Pre-intervention and post-intervention trends in the monthly
incidence of carbapenem-resistant Enterobacteriaceae (CRE) blood-
stream infection (BSI). A signiﬁcant decline in the monthly incidence
rate ratio (IRR) of CRE BSI during the 30-month post-intervention
period was found by Poisson regression.Microbiological data
A total of 1571 unique CRE-positive cultures were detected
during the active surveillance period from rectal swab (65.1%),
urine (10.5%), bloodstream (7.6%), respiratory tract (7.1%),
drainage catheter or surgical specimens (5.9%), invasive sam-
pling of the gastrointestinal tract (i.e. gastric suction, bile cul-
tures, or ascites ﬂuid; 2.3%), skin or wound culture (0.7%), or
other sites (vaginal culture; 0.7%).
K. pneumoniaewas themost frequently isolatedCRE in patients
(1501/1571, 95%). Other CRE isolates included Enterobacter
cloacae (1.0%), Escherichia coli (0.8%), Enterobacter aerogenes
(0.9%), Klebsiella oxytoca (0.8%), Citrobacter freundii (0.8%), Cit-
robacter koseri (0.06%), Proteus mirabilis (0.06%), and Raoultella
planticola (0.06%). Only K. pneumoniae (95%) E. cloacae (2%) and
E. aerogenes (0.8%) were responsible for unique BSI episodes.
Nearly all CRE isolates were resistant to ertapenem (97%),
and most isolates were resistant to meropenem (89%), based
on EUCAST interpretative guidelines [8]. Meropenem MICs
were 16 mg/L in 84% of isolates when tested with the Vitek II
platform. Cross-resistance to colistin (15%) gentamicin (9%)
and tigecycline (31%) was common among BSI isolates during
the study period.
Disk diffusion synergy testing identiﬁed class A carbapene-
mase (KPC type) production as the most common carbapenem
resistance mechanism (>90% among K. pneumoniae isolates).
Class B carbapenemases (metallo-β-lactamases) were
frequently detected in E. cloacae, E. aerogenes, K. oxytoca andClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InfectC. freundii isolates. A subset of KPC-producing K. pneumoniae
isolates were investigated by molecular methods. PCR and
genotyping data showed that the vast majority of tested strains
carried blakpc-3 and belonged to clonal complex 258 (including
sequence type (ST)-258 and ST-512, a single-locus variant of
ST-258, the current hyperepidemic strains in Italy).
Incidence of CRE colonization and BSI
The ﬁrst case of CRE BSI in our institution was detected in
April 2010; there was an early peak in the incidence in June
2010 (n = 11 cases), followed by a brief 2-month decline, before
the incidence steadily increased after September 2010. During
the pre-intervention period, the monthly incidence of CRE BSI
appeared to be increasing at a rate of 0.05 cases/10 000 patient-
days per month, although the incidence rate ratio (IRR) did not
quite reach statistical signiﬁcance (Fig. 1; IRR 1.05, 95% CI
0.99–1.11, p 0.09). The incidence of CRE BSI peaked twice, in
May 2010 and June 2011, and then signiﬁcantly declined in 2012
and 2013 following implementation of the CRE infection con-
trol programme (IRR 0.96, 95% CI 0.92–0.99, p 0.03).
Nevertheless, a short period of increasing CRE colonization and
BSI incidence was observed from May to July in 2013, with a
subsequent decline continuing to the end of the follow-up
period. The signiﬁcant reduction in CRE BSI and colonization
incidence was observed in both non-routinely screened and
routinely screened units (Table 1).
We observed a similar overall decreasing trend in the rate of
CRE-positive rectal swabs (IRR 0.96, 95% CI 0.95–0.97, p
<0.0001), despite an increasing number of submitted samples
(Fig. 2). Therefore, it is unlikely that the decreasing monthly
incidence of CRE colonization was related to the number of
rectal swabs submitted for screening.ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 242–247
TABLE 1. Comparison of carbapenem-resistant
Enterobacteriaceae (CRE) rectal swabs and bloodstream
infection (BSI) infection trends among units during the
intervention period
IRR (95% CI) during
interventiona p
Patients not routinely screened
Geriatric
Rectal swab 0.98 (0.97–0.99) <0.0001
BSI 0.84 (0.91–0.99) 0.04
Long-term-care facility
Rectal swab 0.95 (0.94–0.99) <0.0001
BSI 0.89 (0.82–0.96) 0.003
Medicine
Rectal swab 0.97 (0.97–0.98) <0.0001
BSI 0.96 (0.94–0.98) <0.0001
Surgery
Rectal swab 0.97 (0.97–0.98) <0.0001
BSI 0.96 (0.94–0.98) <0.0001
Patients routinely screened
ICUs
Rectal swab 0.98 (0.97–0.98) <0.0001
BSIb 0.96 (0.94–0.99) 0.006
Transplant
Rectal swab 1.01 (1.00–1.02) 0.003
BSI 0.95 (0.93–0.96) <0.0001
Haematology
Rectal swab 0.94 (0.91–0.97) <0.0001
BSI 0.92 (0.89–0.95) <0.0001
ICU, intensive-care unit; IRR, incidence rate ratio.
aDetermined by Poisson regression of incidence rates per patient unit during the
intervention period.
bThe analysis excluded 11 patients who were transferred to the ICU with CRE
sepsis.
CMI Viale et al. Control of carbapenem-resistant K. pneumoniae 245During the same 30-month intervention period, we also
observed similar trends of decreasing monthly incidence rates
of CRE-positive cultures from respiratory tract (IRR 0.97, p
0.09), urine (IRR 0.95, p 0.02) and surgical specimens or
drainage catheters (IRR 0.95, p 0.02) (Fig. S1). The incidence of
BSI caused by extended-spectrum β-lactamase (ESBL)-0
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FIG. 2. Trends in the number of rectal swabs performed per month
(solid line, left y-axis) and the percentage of cultures positive for
carbapenem-resistant Enterobacteriaceae (CRE) (dotted line, right y-
axis). The solid line superimposed on the percenaget rate of positive
CRE swabs (dotted line) indicates the signiﬁcant decline in the trend of
the incidence rate ratio (IRR) by Poisson regression.
Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiologyproducing Enterobacteriaceae, vancomycin-resistant entero-
cocci or multidrug-resistant non-fermenting Gram-negative
organisms (Pseudomonas aeruginosa and Acinetobacter bauma-
nii) did not signiﬁcantly change during the intervention period
(Fig. S2).
Impact of programme compliance
Monthly reports on CRE screening compliance were averaged
and analysed in relation to the CRE colonization and BSI
incidence rates by Poisson regression, with inclusion of
possible confounding variables of monthly census, monthly
incidence of positive carriers in the institution, and percentage
of rectal swab cultures that became positive within 72 h of
admission as a marker of possible ‘imported cases’. During the
intervention period, the average percentage of ‘imported
cases’ was 14%, ranging from 0% to 32%, without a clear
temporal trend. In the mixed-effect models, institutional CRE
carrier incidence was the only signiﬁcant predictor of BSI
incidence (IRR 1.15, 95% CI 1.5–1.24, p 0.001) among the
variables analysed (monthly census, monthly imported cases,
and programme compliance) (Table S1). However, declining
rates of CRE rectal colonization in the institution were
inversely associated with programme compliance rates (IRR
0.19, 95% CI 0.073–0.52, p 0.001), independently of monthly
hospital census and numbers of imported cases (Table S2).
Notably, the brief period of increasing CRE colonization and
BSI observed 20–24 months after initiation of the infection
control programme occurred at a time when average
compliance rates fell below 75%. The rebounding incidence of
CRE BSI reversed when compliance rates improved in sub-
sequent months (Fig. 3).0.5
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FIG. 3. Relationship between average institutional compliance rates for
rectal screening (bars, right y-axis) and monthly incidence of CRE-
positive rectal swabs (solid line, left y-axis) and bloodstream infection
(dotted line, left-axis).
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246 Clinical Microbiology and Infection, Volume 21 Number 3, March 2015 CMIDiscussionAn analysis in 2011 by the European Antimicrobial Resistance
Surveillance Network (EARS-Net) revealed that 27% of
K. pneumoniae isolates and 3% of Escherichia coli isolates in Italy
were resistant to carbapenem antibiotics (EARS-Net database.
2013. http77www.ecdceuropa.eu). One-third of all
K. pneumoniae isolates were also resistant to third-generation
cephalosporins, ﬂuoroquinolones, and aminoglycosides (EARS-
Net database. 2013. http77www.ecdceuropa.eu). As a result,
few reliable drugs are available to treat hospital-acquired in-
fections caused by Enterobacteriaceae in our region, especially in
patients who have had previous hospitalizations and multiple
courses of antibiotic therapy [9].
In this worrying landscape, comprehensive infection control
activities constitute the frontline strategy for reducing trans-
mission and mortality associated with CRE infection. In a seminal
study, Schwaber et al. analysed the impact of guidelines instituted
by the Israeli Ministry of Health in 2007 that mandated physical
separation and dedicated stafﬁng for hospitalized CRE carriers
[2]. With the nationally implemented intervention, the rates of
CRE acquisition were reduced by nearly ﬁve-fold, and the inci-
dence of new infection relative to carrier prevalence declined
signiﬁcantly. At an institutional level, Ciabotaro et al. described
the practical implementation and impact of the 2007 Israeli
guidelines in their hospital [3]. Investigators reported a 16-fold
reduction in carbapenemase-resistant K. pneumoniae that was
sustained for 30 months. Outside of Israel, however, few studies
have documented similar declines in CRE infections with a similar
programme aimed at containment of CRE [4,5,10]. Moreover,
universal screening and cohorting may not be possible in many
healthcare institutions, because of limitations in physical space,
personnel, and resources.
Our data conﬁrm the effectiveness of policies described by
Schwaber et al. [2] and Ciobotaro et al. [3], and provide evi-
dence that a multifaceted approach is feasible in other in-
stitutions, and can effectively reduce the rates of CRE infection
in a setting of endemically high rates of CRE and ESBL resis-
tance. The strategies implemented in our institution were based
on guidelines issued by our regional health authority, which
were tailored to the available resources of the hospital. After
initiating our infection control programme, we observed a
decrease in the incidence of CRE BSI in our hospital to rates
approaching those observed prior to the nationwide CRE
outbreak in 2010 [11]. Our analysis showed that this reduction
was not coincidental, as CRE-screening compliance rates were
associated with the observed reduction in the incidence of
monthly CRE-positive rectal swabs. Moreover, when average
compliance with the screening protocols waned after 20Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectmonths of the programme, rates of CRE BSI and positive rectal
swabs rebounded, and only decreased once average screening
compliance rates were restored to >75%. In our opinion, the
keys to the success of our programme are the support of the
regional health authority and of our hospital administration, and
the strict control policy applied during the study period.
Our study is subject to several limitations. Similarly to
Ciobotaro et al. [3], we did not utilize a point-prevalence
screening method for carriers recommended by the CDC
(CDC. Guidance for control of carbapenemase-resistant
enterobacteriaceae. 2013. www.cdc.gov/hai/organisms/cre/cre-
toolkit), opting instead for targeting screening of populations
and units expected to be at high risk for serious CRE infection.
Second, because universal screening was not utilized in all pa-
tient populations, deﬁnitive calculation of the CRE carrier
incidence rates in the institution was not possible, and these
were possibly underestimated. Third, compliance with
screening protocols was based primarily on analysis of unit
census reports and submitted cultures. Futhermore, our
multivariate analysis included only a few variables hypothesized
to inﬂuence CRE BSI or carriage incidence; therefore, we
cannot exclude the possibility that other factors may have
impacted on the effectiveness of our intervention. Neverthe-
less, the actual rate of BSI, chosen as an epidemiological marker
of CRE-related disease, because it is deemed to be the most
unambiguous form of CRE infection [12,13], decreased signiﬁ-
cantly hospital-wide and in high-risk units by the end of the
study observation period, conﬁrming the effectiveness of the
intervention. Finally, data on cost-effectiveness considerations
are important in considering the feasibility of an infection
control programme. From this point of view, the practice used
in our hospital during the study period of screening carriers
weekly until three negative swabs are obtained is not cost-
effective, as CRE carriage lasts for months when decontami-
nation treatment is not given [14]. However, the temporal
dynamics of CRE colonization were not well described at the
time when our infection control programme was initiated.
Furthermore, weekly surveillance culturing appeared to have a
collateral effect of reminding healthcare staff to adhere to
contact precautions for the colonized patient.
In conclusion, a comprehensive infection control strategy
against CRE infections, based on screening for CRE colonization
in high-risk populations, cohorting and contact isolation of
colonized or infected patients, intensiﬁed hygiene and cleaning,
a carbapenem-sparing stewardship programme, and patient,
care-giver and staff education, effectively reduced the incidence
of CRE colonization and BSI in a large tertiary-care hospital
located in a region with high endemic rates (>20%) of
carbapenem-resistant K. pneumoniae and ESBL-producing
Enterobacteriaceae. Compliance with the infection controlious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 242–247
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